Petros Isaakidis
Overview
Explore the profile of Petros Isaakidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
1826
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singla R, Khan S, Silsarma A, Chavan V, Mahajan R, Mansoor H, et al.
Clin Infect Dis
. 2025 Mar;
PMID: 40079698
Background: Bedaquiline (BDQ) resistance presents a critical challenge in the fight against tuberculosis (TB), particularly multidrug-resistant (MDR) strains. The emergence of resistance to BDQ, a key drug in treating MDR-TB,...
2.
Polis C, Obare F, Bruce I, Banda C, Haddad L, Heyns A, et al.
Gates Open Res
. 2025 Mar;
9:5.
PMID: 40041042
Background: Expanding contraceptive options could better meet users' diverse needs and preferences. Annovera is a contraceptive vaginal ring that provides a year of pregnancy prevention while remaining under user control...
3.
Garcia-Prats A, Garcia-Cremades M, Cox V, Kredo T, Dunbar R, Schaaf H, et al.
Lancet Child Adolesc Health
. 2025 Jan;
9(2):100-111.
PMID: 39855750
Background: There are few data on the treatment of children and adolescents with multidrug-resistant (MDR) or rifampicin-resistant (RR) tuberculosis, especially with more recently available drugs and regimens. We aimed to...
4.
Khan S, Silsarma A, Mahajan R, Khan S, Davuluri P, Sutar N, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Nov;
37:100481.
PMID: 39497757
Background: Tuberculosis (TB) remains a significant cause of mortality globally, with India accounting for 27% of the estimated number of people with TB. Multidrug-resistant TB (MDR-TB) and isoniazid (INH) resistance...
5.
Mazzilli S, Aslam M, Akhtar J, Miazek M, Wailly Y, Hamid S, et al.
BMC Infect Dis
. 2024 Sep;
24(1):1054.
PMID: 39333922
Background: Hepatitis C virus (HCV) antibody self-testing (HCVST) may help expand screening access and support HCV elimination efforts. Despite potential benefits, HCVST is not currently implemented in Pakistan. This study...
6.
Mongia H, Mamnoon F, Silsarma A, Mahajan R, Dalal A, Galindo M, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Apr;
35:100433.
PMID: 38617837
Background: World Health Organization suggests concurrent bedaquiline-delamanid (BDQ-DLM) as part of individualised regimens for eligible patients with pulmonary drug-resistant tuberculosis (DR-TB); however, data for patients with drug-resistant extrapulmonary tuberculosis (EPTB)...
7.
Arendse K, Walker C, Pfaff C, Lebelo K, Cassidy T, Isaakidis P, et al.
Sci Rep
. 2024 Mar;
14(1):7317.
PMID: 38538754
Psychosocial challenges impact patients' ability to remain on antiretroviral therapy lifelong, magnified by disorganized health-systems and healthcare worker (HCW) attitudes. To address this, Médecins Sans Frontières and the Department of...
8.
Shigayeva A, Gcwensa N, Ndlovu C, Ntumase N, Sabela S, Ohler L, et al.
PLOS Glob Public Health
. 2024 Mar;
4(3):e0003038.
PMID: 38457417
[This corrects the article DOI: 10.1371/journal.pgph.0000336.].
9.
Gamariel F, Isaakidis P, Pulido Tarquino I, Beirao J, OConnell L, Mulieca N, et al.
PLoS One
. 2024 Feb;
19(2):e0299555.
PMID: 38394070
[This corrects the article DOI: 10.1371/journal.pone.0228307.].
10.
Das M, Mathur T, Ravi S, Meneguim A, Iyer A, Mansoor H, et al.
PLoS One
. 2024 Feb;
19(2):e0299482.
PMID: 38381772
[This corrects the article DOI: 10.1371/journal.pone.0248408.].